Advertisement
Singapore markets close in 4 hours 33 minutes
  • Straits Times Index

    3,307.56
    +10.67 (+0.32%)
     
  • Nikkei

    38,236.07
    -37.98 (-0.10%)
     
  • Hang Seng

    18,413.79
    +206.66 (+1.14%)
     
  • FTSE 100

    8,172.15
    +50.91 (+0.63%)
     
  • Bitcoin USD

    59,797.50
    +2,339.41 (+4.07%)
     
  • CMC Crypto 200

    1,285.52
    +14.78 (+1.16%)
     
  • S&P 500

    5,064.20
    +45.81 (+0.91%)
     
  • Dow

    38,225.66
    +322.37 (+0.85%)
     
  • Nasdaq

    15,840.96
    +235.48 (+1.51%)
     
  • Gold

    2,311.70
    +2.10 (+0.09%)
     
  • Crude Oil

    79.22
    +0.27 (+0.34%)
     
  • 10-Yr Bond

    4.5710
    -0.0240 (-0.52%)
     
  • FTSE Bursa Malaysia

    1,587.00
    +6.70 (+0.42%)
     
  • Jakarta Composite Index

    7,129.25
    +11.82 (+0.17%)
     
  • PSE Index

    6,632.67
    -13.88 (-0.21%)
     

Company News for Apr 18, 2024

  • Eli Lilly and Company (LLY) shares rose 0.5% after announcing positive late-stage results for its weight-loss drug Zepbound, which is especially beneficial for overweight individuals with sleep apnea.

  • Shares of Autodesk, Inc. (ADSK) fell 5.8% following news of a delay in the filing of its annual Form 10-K due to an internal investigation into its accounting practices related to free cash flow and adjusted operating margin.

  • Mobileye Global Inc. (MBLY) increased 2.8% after announcing the delivery of its new EyeQ6 Lite system-on-chip, accelerating ADAS upgrades globally.

  • U.S. Bancorp (USB) shares tumbled 3.6% after reporting first-quarter 2024 revenues of $6.69 billion, missing the Zacks Consensus Estimate by 0.16%.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

Eli Lilly and Company (LLY) : Free Stock Analysis Report

U.S. Bancorp (USB) : Free Stock Analysis Report

Autodesk, Inc. (ADSK) : Free Stock Analysis Report

Mobileye Global Inc. (MBLY) : Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research